Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for VRDN stock have an average target of 37.25, with a low estimate of 20 and a high estimate of 61. The average target predicts an increase of 88.23% from the current stock price of 19.79.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$37.25	$38	$61
Change	+1.06%	+88.23%	+92.02%	+208.24%

Analyst Ratings

The average analyst rating for VRDN stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	5	4	4	4	4	4
Buy	6	5	5	5	5	4
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	11	11	11	11	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $27 → $34	Strong Buy	Maintains	$27 → $34	+71.80%	Nov 14, 2024
Serge Belanger Needham	Needham	Strong Buy Reiterates $38	Strong Buy	Reiterates	$38	+92.02%	Nov 13, 2024
Serge Belanger Needham	Needham	Strong Buy Reiterates $38	Strong Buy	Reiterates	$38	+92.02%	Oct 28, 2024
Julian Harrison BTIG	BTIG	Strong Buy Maintains $56 → $61	Strong Buy	Maintains	$56 → $61	+208.24%	Sep 26, 2024
Gregory Renza RBC Capital	RBC Capital	Buy Reiterates $44	Buy	Reiterates	$44	+122.33%	Sep 19, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

287.79K

Decreased by -8.35%

from 314.00K

Revenue Next Year

256.49K

Decreased by -10.88%

from 287.79K

EPS This Year

-3.95

from -5.31

EPS Next Year

-4.27

from -3.95

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	4.46M	1.05M	2.96M	1.77M	314.00K	287.79K	256.49K	42.95M
Revenue Growth	-46.80%	-76.46%	182.19%	-40.20%	-82.28%	-8.35%	-10.88%	16,644.17%
EPS	-20.04	-31.13	-6.66	-4.05	-5.31	-3.95	-4.27	-4.04
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	17	16	11

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	1.1M	1.1M	96.9M
Avg	287,793	256,489	42.9M
Low	98,000	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	234.4%	264.8%	37,685.2%
Avg	-8.3%	-10.9%	16,644.2%
Low	-68.8%	-	-

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	-3.44	-3.42	-2.78
Avg	-3.95	-4.27	-4.04
Low	-4.06	-5.23	-4.56

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.